Insulet Corporation (PODD) is a Healthcare stock trading at $145.68 (as of 2026-06-18), with a market capitalization of $10.04B and a trailing P/E of 33.9. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. Its Omnipod System includes a self-adhesive, disposable tubeless device worn on the body and a handheld personal diabetes manager, sold through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia.